High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium.
An important biologic function of high-molecular-weight kininogen (HK) is to deliver bradykinin (BK) to its cellular receptors. Internalization and degradation of HK may provide a mechanism by which endothelial cells modulate the production of BK and control its activities. Therefore, we investigated the binding and subsequent distribution of biotinylated-HK (biotin-HK) associated with human umbilical vein endothelial cells (HUVEC). HUVEC bound 3 to 4 times more HK and with greater avidity at 1 to 3 hours at 37 degrees C than at 4 degrees C (Bmax = 1.0 +/- 0.02 x 10(7) molecules/cell, kd = 7 +/- 3 nmol/L v Bmax = 2.6 +/- 0.2 x 10(6) molecules/cell, kd = 46 +/- 8 nmol/L). However, there was no evidence that the difference was caused by internalization of HK at the higher temperature. First, the same amount of biotin-HK was associated with nonpermeabilized and permeabilized HUVEC using buffers containing 20 to 50 mumol/L zinc ion in the absence or presence of 2 mmol/L calcium ion. Second, binding of biotin-HK to HUVEC was approximately 92% reversible at 1 hour when the cells were maintained at both 37 degrees C and 4 degrees C. Third, neither chloroquine nor primaquine altered the amount of biotin-HK bound to HUVEC. Fourth, biotin-HK bound to HUVEC was almost completely removed by pronase. Fifth, the nonpermeable dye, crystal violet, almost completely quenched the fluorescence signal emitted by HUVEC-associated fluorescein isothiocyanate (FITC) HK. Finally, the localization of HUVEC-bound FITC-HK was restricted to the membrane as shown by laser scanning confocal microscopy. The expression of HK binding sites had an absolute requirement for metabolic energy, but was not dependent on new protein synthesis. Membrane-bound HK contributed to the anticoagulant nature of endothelial cells by blocking human alpha-thrombin binding and its resultant induction of prostacyclin formation. These studies indicate that HK is not internalized by HUVEC, but remains primarily on cell surfaces to be accessible for BK liberation and to modulate the binding and actions of alpha-thrombin.
Hasan
A A
AA
Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0724, USA.
Cines
D B
DB
Ngaiza
J R
JR
Jaffe
E A
EA
Schmaier
A H
AH
D001777:Blood Coagulation / Q000502:physiology; D001920:Bradykinin / Q000096:biosynthesis; D002462:Cell Membrane / Q000378:metabolism*; D002463:Cell Membrane Permeability / Q000187:drug effects; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism*; D011464:Epoprostenol / Q000096:biosynthesis; D005840:Gentian Violet / Q000494:pharmacology; D006801:Humans; D007704:Kininogens / Q000378:metabolism*; D018613:Microscopy, Confocal; D011402:Pronase / Q000494:pharmacology; D011485:Protein Binding; D018000:Receptors, Peptide / Q000378:metabolism*; D013696:Temperature; D013917:Thrombin / Q000378:metabolism; D014471:Umbilical Veins
D007704:Kininogens; D018000:Receptors, Peptide; C044865:kininogen receptor; D011464:Epoprostenol; D013917:Thrombin; D011402:Pronase; D005840:Gentian Violet; D001920:Bradykinin